Download PDF
Aktuelle Neurologie 2013; 40(10): 574-587
DOI: 10.1055/s-0033-1359892
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Depression bei Morbus Parkinson: Epidemiologie und Therapie

Depression in Parkinson’s Disease: Epidemiology and Treatment
O. Riedel
1   Technische Universität Dresden, Institut für Klinische Psychologie und Psychotherapie
,
R. Dodel
2   Philipps-Universität Marburg, Klinik für Neurologie
,
K. Rohde
3   Division für Neurodegenerative Erkrankungen, Klinik und Poliklinik für Neurologie, Technische Universität Dresden
,
H.-U. Wittchen
1   Technische Universität Dresden, Institut für Klinische Psychologie und Psychotherapie
› Author Affiliations
Further Information

Publication History

Publication Date:
10 December 2013 (online)

Also available at
    Permissions and Reprints

Lernziele

  1. Häufigkeiten und Auftretenswahrscheinlichkeiten depressiver Erkrankungen bei Patienten mit der Parkinson-Krankheit einschätzen zu können.

  2. Bisherige Ergebnisse zur Häufigkeit anhand der verwendeten Studienmethodik einordnen zu können.

  3. Zusammenhänge zwischen depressiven Störungen und soziodemografischen und klinischen Variablen zu erfahren.

  4. Überblick über den aktuellen Stand zur medikamentösen Behandlung depressiver Störungen bei Patienten mit der Parkinson-Krankheit zu gewinnen.

  5. Informationen über weitere Behandlungsansätze zu erhalten.

 

  • Literatur

  • 1 Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones; 1817
    Search in Google Scholar
  • 2 Schrag A, Jahanshahi M, Quinn N. How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Movement Disord 2000; 15: 1112-1118
    CrossrefPubMedSearch in Google Scholar
  • 3 Bach J-P, Riedel O, Klotsche J et al. Impact of complications and comorbidities on treatment costs and health-related quality of life in patients with Parkinson’s disease. J Neurol Sci 2012; 314: 41-47
    CrossrefPubMedSearch in Google Scholar
  • 4 Winter Y, Balzer-Geldsetzer M, Spottke A et al. Longitudinal study of the socioeconomic burden of Parkinson’s disease in Germany. Eur J Neurol 2010; 17: 1156-1163
    CrossrefPubMedSearch in Google Scholar
  • 5 Gallagher DA, Schrag A. Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis 2012; 46: 581-589
    CrossrefPubMedSearch in Google Scholar
  • 6 Reijnders J, Ehrt U, Weber WEJ et al. A systematic review of prevalence studies of depression in Parkinson’s disease. Movement Disord 2008; 23: 183-189
    CrossrefPubMedSearch in Google Scholar
  • 7 Leentjens AFG. Depression in Parkinson’s disease: conceptual issues and clinical challenges. J Geriatr Psychiat Neurol 2004; 17: 120-126
    CrossrefPubMedSearch in Google Scholar
  • 8 Farabaugh AH, Locascio JJ, Yap L et al. Assessing depression and factors possibly associated with depression during the course of Parkinson’s disease. Ann Clin Psychiatry 2011; 23: 171-177
    PubMedSearch in Google Scholar
  • 9 Hu M, Cooper J, Beamish R et al. How well do we recognise non-motor symptoms in a British Parkinson’s disease population?. J Neurol 2011; 258: 1513-1517
    CrossrefPubMedSearch in Google Scholar
  • 10 Marsh L, McDonald WM, Cummings J et al. Provisional diagnostic criteria for depression in Parkinson’s disease: Report of an NINDS/NIMH work group. Movement Disord 2006; 21: 148-158
    CrossrefPubMedSearch in Google Scholar
  • 11 Zheng J, Sun SG, Qiao X et al. Depression in patients with Parkinson’s disease and the associated features. J Huazhong Univ Sci Tech-Med 2009; 29: 725-728
    PubMedSearch in Google Scholar
  • 12 Joutsa J, Martikainen K, Vahlberg T et al. Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism Relat Disord 2012; 18: 155-160
    CrossrefPubMedSearch in Google Scholar
  • 13 Piccinni A, Marazziti D, Veltri A et al. Depressive symptoms in Parkinson’s disease. Compr Psychiat 2012; 53: 727-731
    CrossrefPubMedSearch in Google Scholar
  • 14 Bugalho P, da Silva JA, Cargaleiro I et al. Psychiatric symptoms screening in the early stages of Parkinson’s disease. J Neurol 2012; 259: 124-131
    CrossrefPubMedSearch in Google Scholar
  • 15 Coelho M, Marti MJ, Tolosa E et al. Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol 2010; 257: 1524-1532
    CrossrefPubMedSearch in Google Scholar
  • 16 Riedel O, Heuser I, Klotsche J et al. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD study. J Geriatr Psychiat Neurol 2010; 23: 27-34
    CrossrefPubMedSearch in Google Scholar
  • 17 Cummings JL, Masterman DL. Depression in patients with Parkinson’s disease. Int J Geriatr Psychiatr 1999; 14: 711-718
    CrossrefPubMedSearch in Google Scholar
  • 18 Spica V, Pekmezovic T, Svetel M et al. Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson’s disease. J Neurol 2013; 260: 131-137
    CrossrefPubMedSearch in Google Scholar
  • 19 Anguenot A, Loll PY, Neau JP et al. Depression and Parkinson’s disease: a study of 135 parkinsonian patients. Can J Neurol Sci 2002; 29: 139-146
    PubMedSearch in Google Scholar
  • 20 Burn DJ, Landau S, Hindle JV et al. Parkinson’s disease motor subtypes and mood. Movement Disord 2012; 27: 379-386
    CrossrefPubMedSearch in Google Scholar
  • 21 Schrag A, Jahanshahi M, Quinn NP. What contributes to depression in Parkinson’s disease?. Psychol Med 2001; 31: 65-73
    CrossrefPubMedSearch in Google Scholar
  • 22 Starkstein SE, Petracca G, Chemerinski E et al. Depression in classic versus akinetic-rigid Parkinson’s disease. Movement Disord 1998; 13: 29-33
    CrossrefPubMedSearch in Google Scholar
  • 23 Holroyd S, Currie LJ, Wooten GF. Depression is associated with impairment of ADL, not motor function in Parkinson disease. Neurology 2005; 64: 2134-2135
    CrossrefPubMedSearch in Google Scholar
  • 24 Kessler RC, Petukhova M, Sampson NA et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012; 21: 169-184
    CrossrefPubMedSearch in Google Scholar
  • 25 Solla P, Cannas A, Ibba FC et al. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson’s disease. J Neurol Sci 2012; 323: 33-39
    CrossrefPubMedSearch in Google Scholar
  • 26 Jacob EL, Gatto NM, Thompson A et al. Occurrence of depression and anxiety prior to Parkinson’s disease. Parkinsonism Relat Disord 2010; 16: 576-581
    CrossrefPubMedSearch in Google Scholar
  • 27 Poletti M, De Rosa A, Bonuccelli U. Affective symptoms and cognitive functions in Parkinson’s disease. J Neurol Sci 2012; 317: 97-102
    CrossrefPubMedSearch in Google Scholar
  • 28 Riedel O, Klotsche J, Spottke A et al. Cognitive impairment in 873 patients with idiopathic Parkinson’s disease: results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD). J Neurol 2008; 255: 255-264
    CrossrefPubMedSearch in Google Scholar
  • 29 Starkstein S, Dragovic M, Jorge R et al. Diagnostic criteria for depression in Parkinson’s disease: a study of symptom patterns using latent class analysis. Movement Disord 2011; 26: 2239-2245
    CrossrefPubMedSearch in Google Scholar
  • 30 Morgante L, Colosimo C, Antonini A et al. Psychosis associated to Parkinson’s disease in the early stages: relevance of cognitive decline and depression. J Neurol Neurosurg Psychiatry 2012; 83: 76-82
    CrossrefPubMedSearch in Google Scholar
  • 31 Ziropadja L, Stefanova E, Petrovic M et al. Apathy and depression in Parkinson’s disease: the Belgrade PD study report. Parkinsonism Relat Disord 2012; 18: 339-342
    CrossrefPubMedSearch in Google Scholar
  • 32 Aarsland D, Pahlhagen S, Ballard CG et al. Depression in Parkinson disease – epidemiology, mechanisms and management. Nat Rev Neurol 2012; 8: 35-47
    PubMedSearch in Google Scholar
  • 33 Dooneief G, Mirabello E, Bell K et al. An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch Neurol 1992; 49: 305-307
    CrossrefPubMedSearch in Google Scholar
  • 34 Dissanayaka NNW, Sellbach A, Silburn PA et al. Factors associated with depression in Parkinson’s disease. J Affect Disord 2011; 132: 82-88
    CrossrefPubMedSearch in Google Scholar
  • 35 Kulkantrakorn K, Jirapramukpitak T. A prospective study in one year cumulative incidence of depression after ischemic stroke and Parkinson’s disease: a preliminary study. J Neurol Sci 2007; 263: 165-168
    CrossrefPubMedSearch in Google Scholar
  • 36 Leentjens A, van den Akker M, Metsemakers J et al. Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Movement Disord 2003; 18: 414-418
    CrossrefPubMedSearch in Google Scholar
  • 37 Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 2001; 104: 380-386
    CrossrefPubMedSearch in Google Scholar
  • 38 Skeie GO, Muller B, Haugarvoll K et al. Parkinson disease: associated disorders in the Norwegian population based incident ParkWest study. Parkinsonism Relat Disord 2013; 19: 53-55
    CrossrefPubMedSearch in Google Scholar
  • 39 Meara J, Mitchelmore E, Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age and Ageing 1999; 28: 35-38
    CrossrefPubMedSearch in Google Scholar
  • 40 Osborn DPJ, Fletcher A, Smeeth L et al. Geriatric depression scale scores in a representative sample of 14545 people aged 75 and over in the United Kingdom: results from the MRC Trial of Assessment and Management of Older People in the Community. Int J Geriatr Psychiatr 2002; 17: 375-382
    CrossrefPubMedSearch in Google Scholar
  • 41 Leentjens A, Verhey F, Lousberg R et al. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson’s disease. Int J Geriatr Psychiatr 2000; 15: 644-649
    CrossrefPubMedSearch in Google Scholar
  • 42 Schrag A, Barone P, Brown R et al. Depression rating scales in Parkinson’s disease: critique and recommendations. Movement Disord 2007; 22: 1077-1092
    CrossrefPubMedSearch in Google Scholar
  • 43 DGPPN, BÄK, KBV et al. eds. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Kurzfassung. Berlin, Düsseldorf: 2009
    Search in Google Scholar
  • 44 Seppi K, Weintraub D, Coelho M et al. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson’s disease. Movement Disord 2011; 26: S42-S80
    CrossrefPubMedSearch in Google Scholar
  • 45 Chaudhuri KR, Martinez-Martin P, Antonini A et al. Rotogotine and specific non-motor symptoms of Parkinson’s disease: post-hoc analysis of RECOVER. Parkinsonism Relat Disord 2013; 19: 660-665
    CrossrefPubMedSearch in Google Scholar
  • 46 Franco-Chaves J, Mateus C, Luckenbaugh D et al. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study. J Affect Disord 2013; 149: 319-325
    CrossrefPubMedSearch in Google Scholar
  • 47 Korchounov A, Winter Y, Rossy W. Combined beneficial effect of rasagiline on motor function and depression in de novo PD. Clin Neuropharmacol 2012; 35: 121-124
    CrossrefPubMedSearch in Google Scholar
  • 48 Richard IH, McDermott MP, Kurlan R et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012; 78: 1229-1236
    CrossrefPubMedSearch in Google Scholar
  • 49 Bertaina-Anglade V, La Rochelle CD, Scheller DKA. Antidepressant properties of rotigotine in experimental models of depression. Eur J Pharmacol 2006; 548: 106-114
    CrossrefPubMedSearch in Google Scholar
  • 50 Bauer M, Whybrow PC, Angst J et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. Rev Psiquiatr Clin 2009; 36: 58-76
    PubMedSearch in Google Scholar
  • 51 Devos D, Dujardin K, Poirot I et al. Comparison of desipramine and citalopram treatments for depression in Parkinson’s disease: a double-blind, randomized, placebo-controlled study. Movement Disord 2008; 23: 850-857
    CrossrefPubMedSearch in Google Scholar
  • 52 Wermuth L, Sorensen PS, Timm S et al. Depression in idiopathic Parkinson’s disease treated with citalopram. A placebo-controlled trial. Nord J Psychiatr 1998; 52: 163-169
    CrossrefPubMedSearch in Google Scholar
  • 53 Avila A, Cardona X, Martin-Baranera M et al. Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 2003; 23: 509-513
    CrossrefPubMedSearch in Google Scholar
  • 54 Fregni F, Santos CM, Myczkowski ML et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004; 75: 1171-1174
    CrossrefPubMedSearch in Google Scholar
  • 55 Leentjens AFG, Vreeling FW, Luijckx GJ et al. SSRIs in the treatment of depression in Parkinson’s disease. Int J Geriatr Psychiatr 2003; 18: 552-554
    CrossrefPubMedSearch in Google Scholar
  • 56 Antonini A, Tesei S, Zecchinelli A et al. Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson’s disease and depression: effect on quality of life. Movement Disord 2006; 21: 1119-1122
    CrossrefPubMedSearch in Google Scholar
  • 57 Barone P, Scarzella L, Marconi R et al. Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease – a national multicenter parallel-group randomized study. J Neurol 2006; 253: 601-607
    CrossrefPubMedSearch in Google Scholar
  • 58 Weintraub D, Mavandadi S, Mamikonyan E et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010; 75: 448-455
    CrossrefPubMedSearch in Google Scholar
  • 59 Therapies for depression in Parkinson’s disease. Cochrane Database Syst Rev 2003;
    PubMedSearch in Google Scholar
  • 60 Takahashi H, Kamata M, Yoshida K et al. Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson’s disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports. Prog Neuro-Psychopharmacol Biol Psychiatry 2005; 29: 351-353
    CrossrefPubMedSearch in Google Scholar
  • 61 Lemke MR. Effect of reboxetine on depression in Parkinson’s disease patients. J Clin Psychiatry 2002; 63: 300-304
    CrossrefPubMedSearch in Google Scholar
  • 62 Leentjens AFG, Verhey FRJ, Vreeling FW. Successful treatment of depression in Parkinson’s disease patient with bupropion. Ned Tijdschr Geeeskd 2000; 144: 2157-2159
    PubMedSearch in Google Scholar
  • 63 Stoppe G. Depressionen im Alter. Bundesgesundheitsblatt 2008; 51: 406-410
    PubMedSearch in Google Scholar
  • 64 Ehrt U, Bronnick K, Leentjens AFG et al. Depressive symptom profile in Parkinson’s disease: a comparison with depression in elderly patients without Parkinson’s disease. Int J Geriatr Psychiatr 2006; 21: 252-258
    CrossrefPubMedSearch in Google Scholar
  • 65 Gotham AM, Brown RG, Marsden CD. Depression in Parkinson’s disease – a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986; 49: 381-389
    CrossrefPubMedSearch in Google Scholar
  • 66 Merschdorf U, Berg D, Csoti I et al. Psychopathological symptoms of depression in Parkinson’s disease compared to major depression. Psychopathol 2003; 36: 221-225
    CrossrefPubMedSearch in Google Scholar
  • 67 Kummer A, Cardoso F, Teixeira AL. Suicidal ideation in Parkinson’s disease. CNS Spectr 2009; 14: 431-436
    PubMedSearch in Google Scholar
  • 68 Funkiewiez A, Ardouin C, Caputo E et al. Long-term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-839
    CrossrefPubMedSearch in Google Scholar
  • 69 Soulas T, Gurruchaga JM, Palfi S et al. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease. J Neurol Neurosurg Psychiatry 2008; 79: 952-954
    CrossrefPubMedSearch in Google Scholar
  • 70 Strutt AM, Simpson R, Jankovic J et al. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson’s disease. Eur J Neurol 2012; 19: 121-127
    CrossrefPubMedSearch in Google Scholar
  • 71 Voon V, Krack P, Lang AE et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 2008; 131: 2720-2728
    CrossrefPubMedSearch in Google Scholar
  • 72 Toft M, Lilleeng B, Ramm-Pettersen J et al. Long-Term efficacy and mortality in Parkinson’s disease patients treated with subthalamic stimulation. Movement Disord 2011; 26: 1931-1934
    CrossrefPubMedSearch in Google Scholar
  • 73 Cole K, Vaughan FL. The feasibility of using cognitive behaviour therapy for depression associated with Parkinson’s disease: a literature review. Parkinsonism Relat Disord 2005; 11: 269-276
    PubMedSearch in Google Scholar
  • 74 Dobkin RD, Menza M, Allen LA et al. Cognitive-behavioral therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiat 2011; 168: 1066-1074
    PubMedSearch in Google Scholar
  • 75 Dobkin RD, Allen LA, Menza M. Cognitive-behavioral therapy for depression in Parkinson’s disease: a pilot study. Movement Disord 2007; 22: 946-952
    CrossrefPubMedSearch in Google Scholar
  • 76 Farabaugh A, Locascio JJ, Yap L et al. Cognitive-behavioral therapy for patients with Parkinson’s disease and comorbid major depressive disorder. Psychosomatics 2010; 51: 124-129
    PubMedSearch in Google Scholar
  • 77 Dobkin RD, Menza M, Allen LA et al. Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatri Psychiatr Neurol 2011; 24: 206-214
    PubMedSearch in Google Scholar
  • 78 Brand S, Dodel R, Hautzinger M et al. Depression in Parkinson’s disease. Assessment and treatment. Nervenarzt 2007; 78: 715-727
    CrossrefPubMedSearch in Google Scholar
  • 79 Dobkin RD, Rubino JT, Allen LA et al. Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson’s disease. J Consult Clin Psychol 2012; 80: 694-699
    PubMedSearch in Google Scholar
  • 80 Sproesser E, Viana MA, Quagliato E et al. The effect of psychotherapy in patients with PD: a controlled study. Parkinsonism Relat Disord 2010; 16: 298-300
    CrossrefPubMedSearch in Google Scholar
  • 81 A’Campo LEI, Wekking EM, Spliethoff-Kamminga NGA et al. The benefits of a standardized patient education program for patients with Parkinson’s disease and their caregivers. Parkinsonism Relat Disord 2010; 16: 89-95
    CrossrefPubMedSearch in Google Scholar
  • 82 A’Campo LEI, Wekking EM, Spliethoff-Kamminga NGA et al. Treatment effect modifiers for the patient education programme for Parkinson’s disease. Int J Clin Pract 2012; 66: 77-83
    CrossrefPubMedSearch in Google Scholar
  • 83 Macht M, Gerlich C, Ellgring H et al. Patient education in Parkinson’s disease: formative evaluation of a standardized programme in seven European countries. Patient Educ Couns 2007; 65: 245-252
    CrossrefPubMedSearch in Google Scholar
  • 84 Fitzpatrick L, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson’s disease. Psychol Psychother-Theory Res Pract 2010; 83: 179-192
    PubMedSearch in Google Scholar
  • 85 Strehl U, Birbaumer N. Verhaltensmedizinische Interventionen beim Morbus Parkinson. Weinheim: Beltz; 1996
    Search in Google Scholar
  • 86 Yang S, Sajatovic M, Walter BL. Psychosocial interventions for depression and anxiety in Parkinson’s disease. J Geriatr Psychiatr Neurol 2012; 25: 113-121
    CrossrefPubMedSearch in Google Scholar
  • 87 Hemmeter U, Hemmeter-Spernal J, Krieg J. Sleep deprivation in depression. Expert Rev Neurother 2010; 10: 1101-1115
    CrossrefPubMedSearch in Google Scholar
  • 88 Demet EM, Chicz-Demet A, Fallon JH et al. Sleep deprivation therapy in depressive illness and Parkinson’s disease. Prog Neuro-Psychopharmacol Biol Psychiatry 1999; 23: 753-784
    CrossrefPubMedSearch in Google Scholar
  • 89 Willis GL, Moore C, Armstrong SM. A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson’s disease. Rev Neurosci 2012; 23: 199-226
    PubMedSearch in Google Scholar
  • 90 Paus S, Schmitz-Hubsch T, Wullner U et al. Bright light therapy in Parkinson’s disease: a pilot study. Mov Disord 2007; 22: 1495-1498
    CrossrefPubMedSearch in Google Scholar
  • 91 Fregni F, Simon DK, Wu A et al. Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatr 2005; 76: 1614-1623
    CrossrefPubMedSearch in Google Scholar
  • 92 Pal E, Nagy F, Aschermann Z et al. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Movement Disord 2010; 25: 2311-2317
    CrossrefPubMedSearch in Google Scholar
  • 93 Arun MP, Bharath S, Pal PK et al. Relationship of depression, disability, and quality of life in Parkinson’s disease: a hospital-based case-control study. Neurol India 2011; 59: 185-189
    CrossrefPubMedSearch in Google Scholar
  • 94 Barone P, Antonini A, Colosimo C et al. The Priamo Study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Movement Disord 2009; 24: 1641-1649
    CrossrefPubMedSearch in Google Scholar
  • 95 Braam AW, Beekman ATF, Dewey ME et al. Depression and parkinsonism in older Europeans: results from the EURODEP concerted action. Int J Geriatr Psychiatr 2010; 25: 679-687
    PubMedSearch in Google Scholar
  • 96 Khedr EM, El Fetoh NA, Khalifa H et al. Prevalence of depression, anxiety, dementia and other non motor features of a large cohort of Egyptian Parkinson’s disease patients. Life Sci J 2012; 9: 509-518
    PubMedSearch in Google Scholar
  • 97 Oguru M, Tachibana H, Toda K et al. Apathy and depression in Parkinson disease. J Geriatr Psychiatr Neurol 2010; 23: 35-41
    CrossrefPubMedSearch in Google Scholar
  • 98 Rodriguez-Violante M, Cervantes-Arriaga A, Berlanga-Flores C et al. Prevalence and determinants of depression in Mexican patients with Parkinson’s disease. Clin Neurol Neurosurg 2012; 114: 1293-1296
    CrossrefPubMedSearch in Google Scholar
  • 99 Vanderheyden JE, Gonce M, Bourgeois P et al. Epidemiology of major depression in Belgian parkinsonian patients. Acta Neurol Belg 2010; 110: 148-156
    PubMedSearch in Google Scholar